Abstract
The metabolism of 1 mM benzo(a)pyrene was studied in isolated perfused lung and liver of 5,6-benzoflavone-pretreated rats. Benzo(a)pyrene metabolism by the liver was more rapid than by the lung, but total metabolite formation in the lung at the end of a 120-min perfusion period was comparable to that in the liver. Lung perfusate was characterized by high concentrations of free metabolites, with diols outweighing phenols; in liver perfusate free metabolite concentrations were low, and large quantities of metabolites were found as conjugates in the bile at the end of perfusion. The tissue concentrations of free diols and phenols including the precursors of the main DNA-binding secondary metabolites were higher in the lung than in the liver. These findings explain the similar level of covalent binding in perfused lung and liver previously described (Klaus et al. 1982).
Similar content being viewed by others
Abbreviations
- BP:
-
benzo(a)pyrene
- 9,10-diol:
-
9,10-dihydro9,10-dihydroxy-benzo(a)pyrene
- 4,5-diol:
-
4,5-dihydro-4,5-dihydroxy-benzo(a)pyrene
- 7,8-diol:
-
7,8-dihydro-7,8-dihydroxy-benzo(a)pyrene
- 9-OH:
-
9-hydroxy-benzo(a)pyrene
- 3-OH:
-
3-hydroxybenzo(a)pyrene
- tetrols:
-
7,8,9,10-tetrahydro-7,8,9,10-tetrahydroxy-benzo(a)pyrenes
- BF:
-
5,6-benzoflavone
- TLC:
-
thin-layer chromatography
- HPLC:
-
high-pressure liquid chromatography
References
Aitio A (1973) Glucuronide synthesis in the rat and guinea pig lung. Xenobiotica 3: 13–22
Boroujerdi M, Kung HC, Wilson AGE, Anderson MW (1981) Metabolism and DNA-binding of benzo(a)pyrene in vivo in the rat. Cancer Res 41: 951–957
Camus AM, Aitio A, Sabaidie N, Wahrendorf J, Bartsch H (1984) Metabolism and urinary excretion of mutagenic metabolites of benzo(a)pyrene in C57 and DBA mice strains. Carcinogenesis 5: 35–39
Chipman JK, Hirom PC, Frost GS, Millburn P (1981) The biliary excretion and enterohepatic circulation of benzo(a)pyrene and its metabolites in the rat. Biochem Pharmacol 30: 937–944
Cohen GM, Haws SM, Moore BP, Bridges JW (1976) Benzo(a)pyrene-3-yl hydrogen sulphate, a major ethyl acetate-extractable metabolite of benzo(a)pyrene in human, hamster and rat lung cultures. Biochem Pharmacol 25: 2561–2570
Cohen GM, Uotila P, Hartiala J, Suolinna EM, Simberg N, Pelkonen O (1977) Metabolism and covalent binding of (3H)-benzo(a)pyrene by isolated perfused lungs and short-term tracheal organ cultures of cigarette smoke-exposed rats. Cancer Res 37: 2147–2155
Collins JM, Dedrick RL (1982) Contribution of lungs to total body clearance: linear and nonlinear effects. J Pharm Sci 71: 66–70
Dawson J, Berggren M, Moldéus P (1982) Isolated cells as a model for studying sulfate conjugation and its regulation. In: Mulder GJ, Caldwell J, VanKempen GMJ, Vonk RJ (eds), Sulfate metabolism and conjugation. Taylor & Francis, London, p 135
Deckers-Schmelzle B, Klaus E, Kahl R, Kahl GF (1978) Binding of benzo(a)pyrene metabolites to cellular DNA in perfused rat lungs. Naunyn-Schmiedeberg's Arch Pharmacol 303: 303–307
Emudianughe TS, Caldwell J, Sinclair KA, Smith RL (1983) Species differences in the metabolic conjugation of clofibric acid and clofibrate in laboratory animals and man. Drug Metab Dispos 11: 97–102
Foth H, Mollière M, Kahl R, Jähnchen E, Kahl GF (1984) Covalent binding of benzo(a)pyrene in perfused rat lung following systemic and intratracheal administration. Drug Metab Dispos 12: 760–766
Gozukara EM, Guengerich FP, Miller H, Gelboin HV (1982) Different patterns of benzo(a)pyrene metabolism of purified cytochromes P-450 from methylcholanthrene, β-naphthoflavone and phenobarbital treated rats. Carcinogenesis 3: 129–133
Grimmer G (1982) Krebserregende Substanzen in der Nahrung. Pharm Zeitung 127: 1771–1776
Grover PL (1974) K-region epoxides of polycyclic hydrocarbons: formation and further metabolism by rat-lung preparations. Biochem Pharmacol 23: 333–343
Hems R, Ross BD, Berry MM, Krebs HA (1966) Gluconeogenesis in the perfused rat liver. Biochem J 101: 284–293
Hoiberg CP, Mumma RO (1969) Preparation of sulfate esters. Reactions of various alcohols, phenols, amines, mercaptans, and oximes with sulfuric acid and dicyclohexylcarbodiimide. J Am Chem Soc 91: 4273–4278
Hook GER, Bend JR (1976) Pulmonary metabolism of xenobiotics. Life Sci 18: 279–290
Hundley SG, Freudenthal RJ (1977) High pressure liquid chromatography analysis of benzo(a)pyrene metabolism by microsomal enzymes from rhesus liver and lung. Cancer Res 37: 244–249
Jernström B, Babson JR, Moldéus P, Holmgren A, Reed DJ (1982) Glutathione conjugation and DNA binding of (+)-trans-7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene and (+)7β,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo(a) pyrene in isolated rat hepatocytes. Carcinogenesis 3: 861–866
Kahl GF, Legraverend C, Nebert DW, Pelkonen O (1979) Formation fo benzo(a)pyrene metabolite-nucleoside adducts in perfused rat and mouse liver and in mouse lung slices. Biochem Pharmacol 28: 1051–1056
Kahl GF, Mollière M, Philipp P, Kahl R, Foth H (1984) Activating and detoxifying metabolism of benzo(a)pyrene in the isolated perfused rat lung. In: Grosdanoff P, Baß R, Hackenberg U, Henschler D, Müller D, Klimisch H-J (eds) Problems of inhalatory toxicity studies, BGA Schriften 5/84. MMV Medizin, München
Kapitulnik J, Wislocki PG, Levin W, Yagi H, Jerina DM, Conney AH (1978) Tumorigenicity studies with diol-epoxides of benzo(a)pyrene which indicate that (+)-trans-7β,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydro-benzo(a)pyrene is an ultimate carcinogen in newborn mice. Cancer Res 38: 354–358
Klaus E, Foth H, Kahl R, Kahl GF (1982) Similar level of metabolic activation of benzo(a)pyrene in perfused rat lung and liver and protection of lung by liver in a combined perfusion system. Biochem Biophys Res Commun 105: 596–602
Knight RH, Young L (1958) Biochemical studies of toxic agents. The occurrence of premercapturic acid. Biochem J 70: 111–119
Levine WG (1970) The role of microsomal drug-metabolizing enzymes in the biliary excretion of 3,4-benzpyrene in the rat. J Pharmacol Exp Ther 175: 301–310
Lilienblum W, Walli AK, Bock KW (1982) Differential induction of rat liver microsomal UDP-glucuronosyltransferase activities by various inducing agents. Biochem Pharmacol 31: 907–913
Mehta R, Brown MM, Cohen GM (1979) Metabolism and covalent binding of benzo(a)pyrene in human peripheral lung. Chem Biol Interact 28: 345–358
Miller LL, Bly CG, Watson ML, Bale WF (1951) The dominant role of liver in plasma protein synthesis. J Exp Med 94: 431–453
Moron MS, DePierre JW, Mannervik B (1979) Levels of glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 582: 67–78
Nemoto N, Gelboin HV (1976) Enzymatic conjugation of benzo(a)pyrene oxides, phenols and dihydrodiols with UDP-glucuronic acid. Biochem Pharmacol 25: 1221–1226
Nemoto NN, Takayama S, Gelboin HV (1978) Sulfate conjugation of benzo(a)pyrene metabolites and derivatives. Chem Biol Interact 23: 19–30
Prough RA, Patrizi VW, Okita RT, Masters BSS, Jakobsson SW (1979) Characteristics of benzo(a)pyrene metabolism by kidney, liver and lung microsomal fractions from rodents and humans. Cancer Res 39: 1199–1206
Remmer H (1975) Pulmonary drug-metabolizing enzymes. In: Junod AF, de Haller R (eds) Lung metabolism. Academic Press, New York, p 133
Seifried HE, Birkett DJ, Levine W, Lu AYH, Conney AH, Jerina DM (1977) Effect of 3-methylcholanthrene pretreatment on metabolism by microsomes from lung of genetically “responsive” and “nonresponsive” mice. Arch Biochem Biophys 178: 256–263
Shen AL, Fahl WE, Wrighton SA, Jefcoate CR (1979) Inhibition of benzo(a)pyrene and benzo(a)pyrene 7,8-dihydrodiol metabolism by benzo(a)pyrene quinones. Cancer Res 39: 4123–4129
Takahashi S, Zeydel M (1982) Gamma-glutamyltranspeptidase and glutathione in aging IMR-90 fibroblasts and in differentiating 3T3 L1 preadipocytes. Arch Biochem Biophys 214: 260–267
Vähäkangas K, Nevasaari K, Pelkonen O, Kärki NT (1977) Metabolism of benzo(a)pyrene in isolated perfused lungs from variously-treated rats. Acta Pharmacol Toxicol 41: 129–140
Vähäkangas K, Nevasaari K, Pelkonen O, Kärki NT (1979) Effects of various in vitro-inhibitors of benzo(a)pyrene metabolism in isolated rat lung perfusion. Acta Pharmacol Toxicol 45: 1–8
VanCantfort J, Manil L, Gielen JE, Glatt HR, Oesch F (1979) A new assay for glutathione S-transferase using (3H)benzo(a)pyrene-4,5-oxide as substrate. Biochem Pharmacol 28: 455–460
Wiersma DA, Braselton WE, Roth RA (1982) The influence of flow on the metabolism of perfused benzo(a)pyrene by isolated rat lung. Chem Biol Interact 43: 1–15
Wiersma DA, Roth RA (1983) Clearance of benzo(a)pyrene by isolated rat liver and lung: alterations in perfusion and metabolic capacity. J Pharmacol Exp Ther 225: 121–125
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mollière, M., Foth, H., Kahl, R. et al. Comparison of benzo(a)pyrene metabolism in isolated perfused rat lung and liver. Arch Toxicol 60, 270–277 (1987). https://doi.org/10.1007/BF01234665
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01234665